Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

The reorganization supports Army acquisition reform and continuous adoption of commercial technologies for modern command-and ...

First and only company with 100 approved and active companion diagnostic indications for next-generation sequencing in the ...

PEO C3N is undergoing a major reorganization, changing its name to to the Capability Program Executive Command, Control, ...

A team from the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) has developed an innovative ...

Twenty-five years ago, the release of the first complete Arabidopsis thaliana genome marked a pivotal turning point in plant ...

AWS has been building its own AI chips — and systems — for years now. It just released its third version, known as Trainium3, ...